They used the extraction of exosomal mRNA and detection of mRNA expression of candidate genes related to tumor progression or invasion, such as cyclin-dependent kinase 6 (CDK6), ras homolog family member U (RHOU), and spire type actin nucleation factor 2 (SPIRE2). The gene discussed is RHOU; the disease is neoplasm.